相似文献
1
Social and ethical implications of HIV cure research.
AIDS. 2014 Jun 1;28(9):1247-50. doi: 10.1097/QAD.0000000000000210.
2
Informed consent to HIV cure research.
J Med Ethics. 2017 Feb;43(2):108-113. doi: 10.1136/medethics-2015-103122. Epub 2016 Jun 10.
3
The social value of candidate HIV cures: actualism versus possibilism.
J Med Ethics. 2017 Feb;43(2):118-123. doi: 10.1136/medethics-2015-103125. Epub 2016 Jul 8.
4
Improving on effective antiretroviral therapy: how good will a cure have to be?
J Med Ethics. 2017 Feb;43(2):71-73. doi: 10.1136/medethics-2016-103907. Epub 2016 Dec 5.
5
Afterword: returning to philosophical foundations in research ethics.
J Med Ethics. 2017 Feb;43(2):132-133. doi: 10.1136/medethics-2016-103429. Epub 2016 Jun 27.
6
When to start paediatric testing of the adult HIV cure research agenda?
J Med Ethics. 2017 Feb;43(2):82-86. doi: 10.1136/medethics-2015-103116. Epub 2016 Jun 3.
7
Why cure, why now?
J Med Ethics. 2017 Feb;43(2):67-70. doi: 10.1136/medethics-2015-103113. Epub 2016 Jun 7.
8
Reimagining Inclusivity in Health Care for Sexual Minorities to End the HIV Epidemic: A Student Perspective.
Am J Public Health. 2021 Jul;111(7):1263-1264. doi: 10.2105/AJPH.2021.306346. Epub 2021 Jun 10.
9
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction.
J Med Ethics. 2017 Feb;43(2):65-66. doi: 10.1136/medethics-2016-103427. Epub 2016 May 23.
10
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio.
J Med Ethics. 2017 Feb;43(2):124-127. doi: 10.1136/medethics-2015-103127. Epub 2016 Sep 2.
引用本文的文献
1
Resolving Challenges in HIV Cure-Related Research: Protocol for a Modified Delphi Consensus-Building Process.
JMIR Res Protoc. 2025 Aug 6;14:e67123. doi: 10.2196/67123.
2
Achieving the global agenda toward HIV cure calls for establishing a research-for-cure academy in West and Central Africa.
J Virus Erad. 2025 Jun 27;11(3):100603. doi: 10.1016/j.jve.2025.100603. eCollection 2025 Sep.
3
Development and Evaluation of Decision Partner: A Decision Aid for HIV Remission Clinical Trial Participation.
AIDS Behav. 2025 Jun 10. doi: 10.1007/s10461-025-04764-1.
4
Beliefs about HIV cure: A qualitative study of people living with HIV in Soweto, South Africa.
South Afr J HIV Med. 2025 Jan 30;26(1):1644. doi: 10.4102/sajhivmed.v26i1.1644. eCollection 2025.
5
Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection.
BMC Med Ethics. 2021 Dec 28;22(1):169. doi: 10.1186/s12910-021-00716-1.
6
Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States.
AIDS Res Ther. 2021 Oct 18;18(1):75. doi: 10.1186/s12981-021-00401-8.
7
Recommendations from Thai stakeholders about protecting HIV remission ('cure') trial participants: report from a participatory workshop.
Int Health. 2020 Nov 9;12(6):567-574. doi: 10.1093/inthealth/ihaa067.
8
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study.
Vaccines (Basel). 2020 Jun 23;8(2):334. doi: 10.3390/vaccines8020334.
9
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment.
J Int AIDS Soc. 2020 Feb;23(2):e25443. doi: 10.1002/jia2.25443.
10
Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.
J Int AIDS Soc. 2019 Oct;22(10):e25404. doi: 10.1002/jia2.25404.
本文引用的文献
1
HIV cure research: expanding the ethical considerations.
Ann Intern Med. 2013 Oct 1;159(7):490-1. doi: 10.7326/0003-4819-159-7-201310010-00694.
2
A cure for HIV: where we've been, and where we're headed.
Lancet. 2013 Jun 15;381(9883):2057-8. doi: 10.1016/S0140-6736(13)61180-0.
3
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
Lancet. 2013 Jun 15;381(9883):2109-17. doi: 10.1016/S0140-6736(13)60104-X. Epub 2013 Mar 29.
4
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
PLoS Pathog. 2013 Mar;9(3):e1003211. doi: 10.1371/journal.ppat.1003211. Epub 2013 Mar 14.
5
Ethical considerations in HIV cure research: points to consider.
Curr Opin HIV AIDS. 2013 May;8(3):243-9. doi: 10.1097/COH.0b013e32835ea1c5.
6
Effective HIV prevention: the indispensable role of social science.
J Int AIDS Soc. 2012 Apr 26;15(2):17357. doi: 10.7448/IAS.15.2.17357.
7
Biomedical loopholes, distrusted state, and the politics of HIV/AIDS "cure" in Nigeria.
Afr Aff (Lond). 2011;110(439):191-211. doi: 10.1093/afraf/adr001.
8
Recruitment of HIV/AIDS treatment-naïve patients to clinical trials in the highly active antiretroviral therapy era: influence of gender, sexual orientation and race.
HIV Med. 2011 Mar;12(3):183-91. doi: 10.1111/j.1468-1293.2010.00867.x. Epub 2010 Aug 29.
9
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
N Engl J Med. 2009 Feb 12;360(7):692-8. doi: 10.1056/NEJMoa0802905.
10
Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs.
Global Health. 2008 Feb 27;4:5. doi: 10.1186/1744-8603-4-5.
Zotero 插件